Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients With Type 2 Diabetes Mellitus Managed With Oral Hypoglycemic Agent(s)

Next Previous
X
Search
Trial Profile

A 52-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients With Type 2 Diabetes Mellitus Managed With Oral Hypoglycemic Agent(s)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lorcaserin (Primary)
  • Indications Obesity; Overweight
  • Focus Registrational; Therapeutic Use
  • Acronyms BLOOM-DM
  • Sponsors Arena Pharmaceuticals; Eisai Co Ltd

    • Most Recent Events

    • 24 Oct 2017 Results (n=2483) of post-hoc analysis assessing changes in liver enzymes in patients treated with Lorcaserin for obesity from three pivotal trials (BLOSSOM, BLOOM and BLOOM-DM), presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 17 Sep 2017 Results of a pooled cohort analysis from BLOOM, BLOSSOM, BLOOM-DM trials presented at the Council on Hypertension Scientific Session 2017
    • 13 Jun 2017 Results of post - hoc analysis of 3 trials (BLOOM, BLOSSOM, and BLOOM -DM) assessing efficacy of Lorcaserin by race presented at the 77th Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top